Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.
Sci Rep. 2019 Mar 7;9(1):3823. doi: 10.1038/s41598-019-40518-5.
Sci Rep. 2019.
PMID: 30846826
Free PMC article.
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease.
Smith R, Liu M, Liby T, Bayani N, Bucher E, Chiotti K, Derrick D, Chauchereau A, Heiser L, Alumkal J, Feiler H, Carroll P, Korkola JE.
Smith R, et al.
Sci Rep. 2020 Dec 10;10(1):21750. doi: 10.1038/s41598-020-78798-x.
Sci Rep. 2020.
PMID: 33303959
Free PMC article.
Item in Clipboard
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.
Coleman DJ, Gao L, King CJ, Schwartzman J, Urrutia J, Sehrawat A, Tayou J, Balter A, Burchard J, Chiotti KE, Derrick DS, Sun D, Xia Z, Heiser LM, Alumkal JJ.
Coleman DJ, et al. Among authors: derrick ds.
Oncogene. 2019 Jul;38(28):5658-5669. doi: 10.1038/s41388-019-0815-5. Epub 2019 Apr 17.
Oncogene. 2019.
PMID: 30996246
Free PMC article.
Item in Clipboard
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma.
Lue HW, Derrick DS, Rao S, Van Gaest A, Cheng L, Podolak J, Lawson S, Xue C, Garg D, White R 3rd, Ryan CW, Drake JM, Ritz A, Heiser LM, Thomas GV.
Lue HW, et al. Among authors: derrick ds.
Cell Rep Med. 2021 May 7;2(5):100267. doi: 10.1016/j.xcrm.2021.100267. eCollection 2021 May 18.
Cell Rep Med. 2021.
PMID: 34095877
Free PMC article.
Item in Clipboard
A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.
Gross SM, Dane MA, Smith RL, Devlin KL, McLean IC, Derrick DS, Mills CE, Subramanian K, London AB, Torre D, Evangelista JE, Clarke DJB, Xie Z, Erdem C, Lyons N, Natoli T, Pessa S, Lu X, Mullahoo J, Li J, Adam M, Wassie B, Liu M, Kilburn DF, Liby TA, Bucher E, Sanchez-Aguila C, Daily K, Omberg L, Wang Y, Jacobson C, Yapp C, Chung M, Vidovic D, Lu Y, Schurer S, Lee A, Pillai A, Subramanian A, Papanastasiou M, Fraenkel E, Feiler HS, Mills GB, Jaffe JD, Ma'ayan A, Birtwistle MR, Sorger PK, Korkola JE, Gray JW, Heiser LM.
Gross SM, et al. Among authors: derrick ds.
Commun Biol. 2022 Oct 7;5(1):1066. doi: 10.1038/s42003-022-03975-9.
Commun Biol. 2022.
PMID: 36207580
Free PMC article.
Item in Clipboard
BefA, a microbiota-secreted membrane disrupter, disseminates to the pancreas and increases β cell mass.
Hill JH, Massaquoi MS, Sweeney EG, Wall ES, Jahl P, Bell R, Kallio K, Derrick D, Murtaugh LC, Parthasarathy R, Remington SJ, Round JL, Guillemin K.
Hill JH, et al.
Cell Metab. 2022 Nov 1;34(11):1779-1791.e9. doi: 10.1016/j.cmet.2022.09.001. Epub 2022 Oct 13.
Cell Metab. 2022.
PMID: 36240759
Free PMC article.
Item in Clipboard
Cite
Cite